ARA-290
cardiovascular pulmonary healthimmune support inflammationneuroprotection nerve repair
Dosing Schedule (Subcutaneous)
| Phase | Daily Dose (mg) |
|---|---|
| Standard | 4 mg |
| High Dose | 8 mg |
Frequency: Once per day or every other day (subcutaneous).
Timing: Evening administration is often preferred; rotate sites daily.
Cycle Length: 4–8 weeks.
Need ARA-290?
Lab-tested research peptides from N1 Aminos